Don't expect them in salad yet, but research shows introducing certain genes can turn tomatoes into supercharged nutrient bags.
The US Food and Drug Administration had previously halted the company's test, which can show the potential risk of hereditary diseases.
Jack Dorsey is now CEO of both Twitter and Square. Running one big company is tough. Now he has two.
Technology's advances can sometimes leave us breathless. Get used to it. We're always going to feel that way.
Commentary: Congress may pass antitrolling legislation this year. But that's only the first step toward fixing a broken patent system
Emerald Therapeutics and companies like it want to be the Amazon Web Services of bioscience. If they succeed, they could potentially speed the big, breakthrough discoveries.
Genetically modified Arctic apples clear a government hurdle and look ahead to landing in a grocery store near you.
Biotech startup Suneris has developed a plant-based polymer it says functions like "Lego building blocks for the body," drastically reducing the amount of time it takes to stop a wound from bleeding.
The search giant takes another step into biotech, snapping up a device maker focused on neurodegenerative diseases.
The Google-backed company is taking its mission to extend the human life span further, partnering with biopharmaceutical firm AbbVie.